Clinical Trial Update: Comparing Aquaphor to Atopiclair and EpiCeram in Children With Mild to Moderate Atopic Dermatitis [Phase 4]

View source ↗

Summary

Phase 4 trial comparing Aquaphor, Atopiclair, and EpiCeram in children with mild to moderate atopic dermatitis; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• Aquaphor
• Atopiclair
• EpiCeram

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Atopic Dermatitis | Phase 4 | Status: COMPLETED | Results posted: 2017-05-18